Biotech Snap

A daily 5-min biotech briefing

Latest news

Takeda’s $4B psoriasis pill shows blockbuster promise & DBV's patch puts peanuts back on the menu

Joachim Eeckhout, +1

Ambros launches with $125M for non-opioid drugs & the EU proposes Biotech Act I

Joachim Eeckhout, +1

Yarrow buys a Chinese thyroid drug for $1.37B & Aviceda’s lead eye drug misses key trial

Joachim Eeckhout, +1

Kyverna's CAR-T win in autoimmune disease & Sanofi’s multiple sclerosis drug fails Phase 3

Joachim Eeckhout, +1

AC Immune's promising Parkinson ́s vaccine & a British biotech buys a US company for pennies per share

Joachim Eeckhout, +1

Lilly breaks records with 29% weight loss & Zealand inks $2.5B deal with China's OTR

Joachim Eeckhout

D3 Bio lands $108M for its KRAS cancer drug & Formation Bio launches a startup with a $605M deal

Joachim Eeckhout

Terns’ new data challenges Novartis & Pfizer buys a Chinese obesity pill

Joachim Eeckhout

Mirum's $620M acquisition of Bluejay & BioNTech’s CTLA-4 safety trade-offs

Joachim Eeckhout

Star Therapeutics’ phase 1/2 win in bleeding disorder

Joachim Eeckhout

Crescent's ADC deal with Kelun & Pharvaris' Phase 3 win in hereditary angioedema

Joachim Eeckhout

Capricor’s Duchenne comeback & Triana's $120M molecular glue degrader

Joachim Eeckhout

1 2 3 4 5 6 7 8